Chart Review: Unresectable/Metastatic Cholangiocarcinoma Treated With Irinotecan, Capecitabine and Celecoxib

Testing Olaparib and AZD6738 in IDH1 and IDH2 Mutant Tumors

NCT03878095 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

NCT00022698 ·Status: COMPLETED ·Phase: PHASE2

Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer

NCT00250835 ·Status: TERMINATED ·Phase: PHASE2

Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery

NCT00466505 ·Status: COMPLETED ·Phase: PHASE2

Molecular Profiling of Advanced Biliary Tract Cancers

NCT04318834 ·Status: RECRUITING ·Phase: NA

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

NCT00506168 ·Status: TERMINATED ·Phase: PHASE2

Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation

NCT01151761 ·Status: TERMINATED ·Phase: PHASE2

A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts

NCT01007552 ·Status: COMPLETED ·Phase: PHASE2

Cetuximab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and/or Lung

NCT00557102 ·Status: COMPLETED ·Phase: PHASE2

Cetuximab and Capecitabine in Treating Patients With Metastatic Colorectal Cancer That Failed Irinotecan Treatment

NCT00538291 ·Status: TERMINATED ·Phase: PHASE2

Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations

NCT04042831 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Bevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors

NCT00356889 ·Status: COMPLETED ·Phase: PHASE2

A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer

NCT01729923 ·Status: TERMINATED ·Phase: PHASE2

Celecoxib, Recombinant Interferon Alfa-2b, and Rintatolimod in Treating Patients With Colorectal Cancer Metastatic to the Liver

NCT03403634 ·Status: COMPLETED ·Phase: PHASE2

A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer

NCT00642603 ·Status: TERMINATED ·Phase: PHASE2

Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen

NCT00250029 ·Status: COMPLETED ·Phase: NA

Irinotecan and Cetuximab for Colorectal Cancer as Second Line Therapy

NCT00336856 ·Status: COMPLETED ·Phase: PHASE2

Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION

NCT01383746 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

NCT00084721 ·Status: COMPLETED ·Phase: PHASE1

A Study of Irinotecan, Cisplatin and Celebrex in Patients With Metastatic or Unresectable Esophageal Cancer

NCT00183807 ·Status: TERMINATED ·Phase: PHASE2

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

NCT01280643 ·Status: TERMINATED ·Phase: NA

Utomilumab, Cetuximab, and Irinotecan Hydrochloride in Treating Patients With Metastatic Colorectal Cancer

NCT03290937 ·Status: COMPLETED ·Phase: PHASE1

Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

NCT00499369 ·Status: TERMINATED ·Phase: PHASE3

Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens

NCT05821582 ·Status: WITHDRAWN

Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer

NCT00002933 ·Status: COMPLETED ·Phase: PHASE2